Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “United Kingdom”
- Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPCRecruiting
Sponsor: Novartis Pharmaceuticals
Prostate Cancer
United States, Australia, Brazil, China, Hong Kong +6 more
Sponsor: Mission Therapeutics
Parkinson's Disease (PD) · Mild to Moderate Parkinson's Disease · Early Stage Parkinson's Disease
Australia, France, Germany, United Kingdom
Sponsor: Boehringer Ingelheim
Extrapulmonary Neuroendocrine Cancer (epNEC)
United States, Argentina, Australia, Austria, Belgium +24 more
- A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic DermatitisActive Not Recruiting
Sponsor: Incyte Corporation
Atopic Dermatitis
United States, Belgium, Canada, France, Germany +5 more
Sponsor: GlaxoSmithKline
Anxiety Disorders
United Kingdom
- Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for HemodialysisCompleted
Sponsor: Humacyte, Inc.
Renal Failure · End Stage Renal Disease · Hemodialysis · Vascular Access
United States, Germany, Israel, Poland, Portugal +1 more
- GPX4 Expression After Kono-S vs Conventional AnastomosisNot Yet Recruiting
Sponsor: East Kent Hospitals University NHS Foundation Trust
Chrohn's Disease
United Kingdom
Sponsor: Alexion Pharmaceuticals, Inc.
BAG3 Mutation Associated Dilated Cardiomyopathy
United States, Italy, Spain, United Kingdom
Sponsor: AstraZeneca
Breast Cancer, Early Breast Cancer
United States, Argentina, Australia, Austria, Belgium +34 more
Sponsor: Vico Therapeutics B. V.
Spinocerebellar Ataxia Type 1 · Spinocerebellar Ataxia Type 3 · Huntington Disease
Denmark, France, Germany, Israel, Netherlands +1 more
Sponsor: Novartis Pharmaceuticals
Chronic Spontaneous Urticaria
Argentina, Brazil, Bulgaria, Canada, Czechia +18 more
Sponsor: Amgen
Generalized Myasthenia Gravis
United States, France, Spain, United Kingdom
- A Randomized, Double-blind 2-arm, Followed by an Open-label 1-arm, NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
Sjogrens Syndrome
United States, Argentina, Australia, Austria, Belgium +30 more
- Physical Activity Intervention for MPSRecruiting
Sponsor: Brunel University
Mucopolysaccharidosis (MPS)
United Kingdom
Sponsor: University of East Anglia
Stroke · Psychological Flexibility · Acceptance and Commitment Therapy
United Kingdom
- A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and LymphomasRecruiting
Sponsor: Novartis Pharmaceuticals
Advanced Solid Tumor · Diffuse Large B Cell Lymphoma · Lymphoma, T-Cell · Mesothelioma, Malignant
United States, France, Italy, Poland, South Korea +2 more
Sponsor: University of Salford
Transtibial Amputation · Lower Limb Amputation · Prosthesis Users
United Kingdom
Sponsor: Regeneron Pharmaceuticals
Pulmonary Arterial Hypertension (PAH)
United States, Australia, Belgium, France, Germany +5 more
- DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine CancersNot Yet Recruiting
Sponsor: Boehringer Ingelheim
Small Cell Lung Cancer · Large Cell Neuroendocrine Lung Carcinoma · Extrapulmonary Neuroendocrine Carcinoma of Small Cell Histology · Extrapulmonary Neuroendocrine Carcinoma of Large Cell Histology
United States, Australia, Belgium, China, France +6 more
Sponsor: University of Oxford
Myocardial Injury · Atherosclerosis Cardiovascular Disease · Cardiac Imaging Techniques · Genetics
United Kingdom
Sponsor: Bayer
Advanced Non-small Cell Lung Cancer, HER2 Mutation
United States, Argentina, Australia, Austria, Belgium +31 more
Sponsor: Boehringer Ingelheim
Proteinuric Kidney Diseases
United States, Argentina, Australia, Belgium, Brazil +28 more
- Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic AlterationsActive Not Recruiting
Sponsor: Daiichi Sankyo
Metastatic Non Small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +23 more
Sponsor: Tenax Therapeutics, Inc.
Pulmonary Hypertension Associated With HFpEF
United States, Argentina, Austria, Brazil, Bulgaria +10 more
Sponsor: AstraZeneca
Asthma · Eosinophilic Granulomatosis With Polyangiitis (EGPA) · Hypereosinophilic Syndrome (HES)
United States, Argentina, Austria, Belgium, Canada +9 more